Literature DB >> 16397838

Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.

S von Delius1, C Lersch, E Schulte-Frohlinde, F Fend, M Dobritz, R M Schmid, F Eckel.   

Abstract

The occurrence of primary hepatocellular carcinoma (HCC) in patients with hereditary hemochromatosis (HH) is well known. Thereby, the development of liver cirrhosis seems to be a prerequisite. Whether or not a hepatic iron overload in the context of hereditary hemochromatosis is an independent risk factor for HCC remains unclear. To date there are only a few reports about HCC arising in non-cirrhotic livers in the presence of HH. We report the case of a 64-year-old man who presented to our outpatient clinic with HCC. Liver cirrhosis could be excluded. Detailed exploration of the patient's history revealed that he had been treated by venesection for about 10 years up to 15 years ago. Subsequent investigations showed an elevated serum ferritin and transferrin saturation. The diagnosis of HH was confirmed by genetic testing, with homozygosity for the Cys282Tyr mutation. The patient received palliative chemotherapy and finally died 15 months after initial diagnosis of HCC.

Entities:  

Mesh:

Year:  2006        PMID: 16397838     DOI: 10.1055/s-2005-858567

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  5 in total

1.  Protective altruistic phlebotomy: hereditary haemochromatosis presenting as hepatocellular carcinoma in a non-cirrhotic 83-year-old man.

Authors:  Kohtaro Ooka; Ifeyinwa Onyiuke; Xuchen Zhang; Tamar Hamosh Taddei
Journal:  BMJ Case Rep       Date:  2016-09-02

2.  [Osteoarthritis in hereditary metabolic diseases].

Authors:  J Zwerina; T Dallos
Journal:  Orthopade       Date:  2010-06       Impact factor: 1.087

Review 3.  [Osteoarthritis in hereditary metabolic diseases].

Authors:  J Zwerina; T Dallos
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

4.  Survival and development of health conditions after iron depletion therapy in C282Y-linked hemochromatosis patients.

Authors:  Paul C Adams; Lucie Richard; Matthew Weir; Mark Speechley
Journal:  Can Liver J       Date:  2021-11-11

Review 5.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.